Home
Advanced Search
Help
Update History
Statistics
Downloads
The Barton Group

Predicted interactions involving protein PRKCZ, PKC2: Protein kinase C zeta type (IPI00013749) that score above 2.5

Click on the protein name for more information about the protein.

The Score column is the predicted score of interaction between the two proteins

Click on the Evidence link to view a breakdown of the information about the predicted interaction.

Key
Module ScoreDatabases
Where interaction is observed in another database a link is provided:

Protein 1 (?)Protein 2 (?) Name of Protein 2 Module Scores (?) Scores (?) Evidence (?) Database (?)
PRKCZ YWHAH YWHAH, YWHA1: 14-3-3 protein eta 61.50 Evidence
PRKCZ MAPK3 MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 44.40 Evidence
PRKCZ FYN FYN: Proto-oncogene tyrosine-protein kinase Fyn 33.90 Evidence
PRKCZ PLCB1 PLCB1, KIAA0581: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta- 32.80 Evidence
PRKCZ PRKCA PRKCA, PKCA, PRKACA: Protein kinase C alpha type 25.00 Evidence
PRKCZ CALM2 CALM1, CALM, CALM2, CAM2, CALM3, CALML2, CAM, CAMB, CAM3, CAM1, CAMC, CAMIII: Ca 22.40 Evidence
PRKCZ MAP2K2 MAP2K2, MEK2, MKK2, PRKMK2: Dual specificity mitogen-activated protein kinase ki 22.20 Evidence
PRKCZ ZAP70 ZAP70: Uncharacterized protein ZAP70 22.20 Evidence
PRKCZ DUSP6 DUSP6, MKP3, PYST1: Dual specificity protein phosphatase 6 20.50 Evidence
PRKCZ BRAF BRAF, BRAF1, RAFB1: B-Raf proto-oncogene serine/threonine-protein kinase 20.40 Evidence
PRKCZ MAP2K1 MAP2K1, MEK1, PRKMK1: Dual specificity mitogen-activated protein kinase kinase 1 20.40 Evidence
PRKCZ CAMK1 CAMK1: Calcium/calmodulin-dependent protein kinase type 1 20.40 Evidence
PRKCZ PARD6A PARD6A, PAR6A: Partitioning defective 6 homolog alpha 19.50 Evidence
PRKCZ YWHAB YWHAB: 14-3-3 protein beta/alpha 18.90 Evidence O
PRKCZ CDC2L5 CDC2L5, CDC2L, CHED, KIAA1791: Cell division cycle 2-like protein kinase 5 17.60 Evidence
PRKCZ MKNK1 MKNK1, MNK1: MAP kinase-interacting serine/threonine-protein kinase 1 17.60 Evidence
PRKCZ DUSP16 DUSP16, KIAA1700, MKP7: Dual specificity protein phosphatase 16 17.60 Evidence
PRKCZ RPS6KA2 RPS6KA2, RSK3: Ribosomal protein S6 kinase alpha-2 17.60 Evidence
PRKCZ CDC25A CDC25A: M-phase inducer phosphatase 1 17.60 Evidence
PRKCZ PRKCG PRKCG, PKCG: Protein kinase C gamma type 16.20 Evidence
PRKCZ GSK3A GSK3A: Glycogen synthase kinase-3 alpha 16.20 Evidence
PRKCZ EFNB2 EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor 15.80 Evidence
PRKCZ CRIP2 CRIP2, CRP2: Cysteine-rich protein 2 15.10 Evidence
PRKCZ SGK2 SGK2: Serine/threonine-protein kinase Sgk2 15.00 Evidence
PRKCZ NRAS NRAS, HRAS1: GTPase NRas precursor 13.70 Evidence
PRKCZ JAK2 JAK2: Tyrosine-protein kinase JAK2 13.70 Evidence
PRKCZ PRKCE PRKCE, PKCE: Protein kinase C epsilon type 13.50 Evidence
PRKCZ PRKCI PRKCI, DXS1179E: Protein kinase C iota type 13.2 Evidence
PRKCZ RAF1 RAF1, RAF: RAF proto-oncogene serine/threonine-protein kinase 12.10 Evidence O
PRKCZ STAT5A STAT5A, STAT5: Signal transducer and activator of transcription 5A 11.80 Evidence
PRKCZ PLCB3 PLCB3: 1-phosphatidylinositol-4,5-bisphosphate phosphodiesterase beta-3 11.80 Evidence
PRKCZ RAP1B RAP1B, OK/SW-cl.11: Ras-related protein Rap-1b precursor 11.80 Evidence
PRKCZ RGS16 RGS16, RGSR: Regulator of G-protein signaling 16 11.5 Evidence
PRKCZ PARD3 N/A 10.40 Evidence
PRKCZ DYRK3 N/A 10.40 Evidence
PRKCZ YWHAZ YWHAZ: 14-3-3 protein zeta/delta 10.00 Evidence
PRKCZ VAV1 VAV1, VAV: Proto-oncogene vav 9.0 Evidence
PRKCZ WAS WAS, IMD2: Wiskott-Aldrich syndrome protein 9.0 Evidence
PRKCZ STAT6 STAT6: Signal transducer and activator of transcription 6 9.0 Evidence
PRKCZ DUSP1 DUSP1, CL100, MKP1, PTPN10, VH1: Dual specificity protein phosphatase 1 8.96 Evidence
PRKCZ IKBKB IKBKB, IKKB: Inhibitor of nuclear factor kappa-B kinase subunit beta 8.92 Evidence
PRKCZ MARK4 N/A 8.01 Evidence
PRKCZ CSF1R CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor 7.52 Evidence
PRKCZ FLT1 FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor 7.52 Evidence
PRKCZ PDGFRB PDGFRB: Beta-type platelet-derived growth factor receptor precursor 7.52 Evidence
PRKCZ GRIN2A GRIN2A, NMDAR2A: Glutamate [NMDA] receptor subunit epsilon-1 precursor 6.78 Evidence
PRKCZ TJP2 TJP2, X104, ZO2: Tight junction protein ZO-2 6.14 Evidence
PRKCZ CBL CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL 5.84 Evidence
PRKCZ TGFBR1 TGFBR1: TGF-beta receptor type-1 precursor 5.84 Evidence
PRKCZ INSR INSR: Insulin receptor precursor 5.84 Evidence
PRKCZ KIT KIT: Mast/stem cell growth factor receptor precursor 5.63 Evidence
PRKCZ BCAR1 BCAR1, CAS, CRKAS: Breast cancer anti-estrogen resistance protein 1 5.50 Evidence
PRKCZ DSTN DSTN, ACTDP, DSN: Destrin 5.15 Evidence
PRKCZ HSP90AA1 Hsp89-alpha-delta-N 4.47 Evidence
PRKCZ EGFR EGFR, ERBB1: Epidermal growth factor receptor precursor 4.01 Evidence
PRKCZ KDR KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor 3.92 Evidence
PRKCZ CHRM2 CHRM2: Muscarinic acetylcholine receptor M2 3.92 Evidence
PRKCZ HSF1 HSF1, HSTF1: Heat shock factor protein 1 3.46 Evidence
PRKCZ JUN JUN: Transcription factor AP-1 3.46 Evidence
PRKCZ FBXO4 FBXO4, FBX4: F-box only protein 4 3.34 Evidence
PRKCZ RPS6KA3 RPS6KA3, ISPK1, RSK2: Ribosomal protein S6 kinase alpha-3 3.32 Evidence
PRKCZ FIGF FIGF, VEGFD: Vascular endothelial growth factor D precursor 3.13 Evidence
PRKCZ SMAD2 SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 3.12 Evidence
PRKCZ EFNA1 EFNA1, EPLG1, LERK1, TNFAIP4: Ephrin-A1 precursor 3.02 Evidence
PRKCZ GNA12 GNA12: Guanine nucleotide-binding protein alpha-12 subunit 2.99 Evidence
PRKCZ SMAD3 SMAD3, MADH3: Mothers against decapentaplegic homolog 3 2.67 Evidence
PRKCZ CDC42 N/A 2.54 Evidence
PRKCZ NFKBIA NFKBIA, IKBA, MAD3, NFKBI: NF-kappa-B inhibitor alpha 2.53 Evidence